/Companies

CARGO Therapeutics

San Mateo, US · Founded 2019 · Delaware corporation · 26 employees on LinkedIn · 8 known investors

Find your way into CARGO Therapeutics

Sign up to see every warm intro you have to CARGO Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the CARGO Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Launched by Samsara in partnership with CAR T pioneers, advancing a clinically validated CD22 CAR T for lymphoma.

Founders & leadership

GCGina Chapman
Gina ChapmanPresident & Chief Executive Officer2022–2025Gina Chapman is an executive with over 30 years of biopharma leadership experience across development, portfolio strategy, commercialization, business development, and operations at organizations ranging from startups to mature companies. She has served as CEO and Board Director, and recently led fundraising efforts including an IPO.
AR
Anup RadhakrishnanInterim Chief Executive Officer2025–2025
CG
Cassandra Gianna LucaNamed on SEC filing
JW
Jeffrey WalshNamed on SEC filing
KV
Krishnan ViswanadhanNamed on SEC filing

Board

AB
Abraham BassanBoard director
CMCrystal Mackall
Crystal MackallBoard directorScientific Advisory Board - Oncology; Director, Stanford Center for Cancer Cell Therapy at Red Tree Venture
HL
Heath LukatchBoard director
JO
John OrwinBoard director

Investors · 8

Reported raises · per SEC filings

Form D private placements

$68.8M disclosed across 1 round · 2023

▶$68.8MraisedMar 2023 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gina ChapmanExecutive Officer, Director
  • Abraham BassanDirector
  • Cassandra Gianna LucaDirector
  • Jeffrey WalshDirector
  • Krishnan ViswanadhanDirector
  • Crystal MackallDirector
  • Heath LukatchDirector
  • John OrwinDirector
  • Anup RadhakrishnanExecutive Officer
Offering amount
$200.8M
Amount sold
$68.8M
First sale
Feb 2023
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

What does CARGO Therapeutics do?
Launched by Samsara in partnership with CAR T pioneers, advancing a clinically validated CD22 CAR T for lymphoma.
Who are CARGO Therapeutics's investors?
CARGO Therapeutics's investors include Nextech Invest, Red Tree Venture, Samsara BioCapital, Wellington Management, Ally Bridge Group, Janus Henderson Investors, Perceptive Xontogeny Venture, Third Rock Ventures.
How much funding has CARGO Therapeutics raised?
CARGO Therapeutics has disclosed $68.8M raised across 1 round.
Where is CARGO Therapeutics headquartered?
CARGO Therapeutics is headquartered in San Mateo, US.